Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz

June 7, 2023
Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared HolzMerck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz

Jared Holz, Mizuho healthcare sector specialist, joins ‘Fast Money’ to discuss Merck’s lawsuit against the federal government over Medicare drug pricing.

Share This

Latest Mizuho News

Payment stocks down due policy uncertainty, says Mizuho’s Dan Dolev

Payment stocks down due policy uncertainty, says Mizuho’s Dan Dolev

January 13, 2026
Why Dutch Bros is a top stock pick for 2026, while Starbucks lags

Why Dutch Bros is a top stock pick for 2026, while Starbucks lags

December 23, 2025
Keeping current furniture tariff rates benefits home furnishings sector: Mizuho’s Bellinger

Keeping current furniture tariff rates benefits home furnishings sector: Mizuho’s Bellinger

January 2, 2026

Mizuho news from around the globe

back-to-top-blue